Ilan Daskal

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Hercules, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Donna T. Rossi, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ilan Daskal

Form 4 holding EVP, CFO

VIAVI SOLUTIONS INC.

Security class
Market Stock Units
Shares / value
37,880
Estimated value
$768,186
Report date
28 Nov 2025
Price
$10.14
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, CFO

VIAVI SOLUTIONS INC.

Security class
Restricted Stock Unit
Shares / value
37,878
Estimated value
$768,176
Report date
28 Nov 2025
Price
$10.14
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Financial Officer

BIO-RAD LABORATORIES, INC.

Security class
Bio-Rad A Common Stock
Shares / value
2,486
Estimated value
$761,079
Report date
02 Sep 2023
Price
$306.12
Ownership
Direct
Form 4 holding EVP, Chief Financial Officer

BIO-RAD LABORATORIES, INC.

Security class
Restricted Stock Units
Shares / value
542
Estimated value
$162,145
Report date
02 Sep 2023
Price
$299.16
Ownership
Direct
Underlying class
Bio-Rad A Common Stock
Underlying amount
Form 4 holding Director

NATUS MEDICAL INC

Security class
Common Stock, $0.001 par value per share
Shares / value
0
Estimated value
Report date
21 Jul 2022
Price
$33.50
Ownership
Direct

Insider Reports Filed by Ilan Daskal

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .